Profiel
Steven Hamburger worked as the VP, Head-Regulatory Affairs & Quality Assurance at Tarveda Therapeutics, Inc. from 2018 to 2019.
He then served as the Vice President & Head-Regulatory Affairs at Checkmate Pharmaceuticals, Inc. He also worked in Clinical Regulatory Affairs at FerGene, Inc. Currently, he is the Senior VP-Regulatory Affairs & Quality Assurance at Oncternal Therapeutics, Inc. from 2021 to 2023.
Dr. Hamburger holds a graduate degree from Butler University, an undergraduate degree from the University of Iowa, and a doctorate degree from The Indiana University School of Medicine.
Eerdere bekende functies van Steven Hamburger
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Algemeen Adviseur | 02-03-2023 |
| CHECKMATE PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-11-2020 |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Algemeen Adviseur | 01-10-2019 |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Algemeen Adviseur | - |
Opleiding van Steven Hamburger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Butler University
Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
The Indiana University School of Medicine
The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
















